Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

408
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
408
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

212
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Real-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review.

JMIR AI·2026
Same author

Real-World Evidence Synthesis of Digital Scribes Using Ambient Listening and Generative Artificial Intelligence for Clinician Documentation Workflows: Rapid Review.

JMIR AI·2025
Same author

Pedestrian detection model based on Tiny-Yolov3 architecture for wearable devices to visually impaired assistance.

Frontiers in robotics and AI·2023
Same author

Development of an Intelligent System for the Monitoring and Diagnosis of the Well-Being.

Sensors (Basel, Switzerland)·2022
Same author

Brain Hemorrhage Classification in CT Scan Images Using Minimalist Machine Learning.

Diagnostics (Basel, Switzerland)·2021
Same author

NanoChest-Net: A Simple Convolutional Network for Radiological Studies Classification.

Diagnostics (Basel, Switzerland)·2021

Related Experiment Video

Updated: Aug 9, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

A Novel Bioinspired Algorithm for Mixed and Incomplete Breast Cancer Data Classification.

David González-Patiño1, Yenny Villuendas-Rey2, Magdalena Saldaña-Pérez1

  • 1Centro de Investigación en Computación, Instituto Politécnico Nacional, Ciudad de México 07738, Mexico.

International Journal of Environmental Research and Public Health
|February 25, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces AISAC-MMD, a novel algorithm for early cancer diagnosis, outperforming existing methods on mixed and missing data. Improved classification enhances patient survival rates.

Keywords:
artificial intelligencebio-inspired algorithmsbreast cancermachine learning

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Related Experiment Videos

Last Updated: Aug 9, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K

Area of Science:

  • Medical Informatics
  • Machine Learning
  • Bioinformatics

Background:

  • Accurate cancer pre-diagnosis is crucial for improving patient survival rates.
  • Medical datasets often contain missing or mixed (numerical and categorical) values, posing challenges for existing classification algorithms.
  • Few algorithms effectively handle datasets with both missing and mixed data types.

Purpose of the Study:

  • To modify an existing classification algorithm to effectively handle datasets with missing and mixed values for improved cancer classification.
  • To evaluate the performance of the modified algorithm against classical and bio-inspired methods.

Main Methods:

  • Modification of the AISAC algorithm to create AISAC-MMD (Mixed and Missing Data).
  • Training and testing AISAC-MMD on datasets with missing and mixed values.
  • Comparative analysis with established algorithms like Nearest Neighbor, C4.5, Naïve Bayes, ALVOT, Naïve Associative Classifier, AIRS1, Immunos1, and CLONALG.

Main Results:

  • The AISAC-MMD algorithm demonstrated significantly superior performance compared to classical and bio-inspired classification algorithms.
  • Statistical analysis confirmed the enhanced classification accuracy of AISAC-MMD, particularly in breast cancer detection.
  • The modified algorithm effectively addressed challenges posed by missing and mixed data types.

Conclusions:

  • AISAC-MMD offers a robust solution for cancer classification, especially with complex, real-world medical data.
  • The algorithm's ability to handle missing and mixed data significantly improves early cancer diagnosis accuracy.
  • This advancement holds potential for enhancing patient survival through more effective early detection strategies.